v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER SHARE OF COMMON STOCK

The following table reflects the calculation of basic net income (loss) per share of Common Stock (in dollars, except share amounts):

 

   Three Months Ended   Three Months Ended 
   March 31, 2026   March 31, 2025 
Basic and diluted net loss per Common Stock          
Numerator:          
Net loss  $(1,930,884)  $(2,902,828)
Denominator:          
Basic and diluted weighted average Common Stock outstanding   148,000,149    2,322,772 
Basic and diluted net loss per Common Stock  $(0.01)  $(1.25)

 

   Nine Months Ended   Nine Months Ended 
   March 31, 2026   March 31, 2025 
Basic net income per Common Stock          
Numerator:          
Net income  $4,412,993   $7,425,515 
Denominator:          
Basic weighted average Common Stock outstanding   116,647,478    975,727 
Basic net income per Common Stock  $0.04   $7.61 

 

The following table reflects the calculation of diluted net income (loss) per share of Common Stock (in dollars, except share amounts):

 

   Nine Months Ended-   Nine Months Ended- 
   March 31, 2026   March 31, 2025 
Diluted net income per Common Stock          
Numerator:          
Net income  $4,412,993   $7,425,515 
Change in fair value of financial instruments   1,073,373    (13,979,733)
Interest on dilutive instruments   1,587,348    6,050,871 
Allocation of net income, as adjusted  $7,073,714   $(503,347)
Denominator:          
Dilutive weighted average Common Stock outstanding   116,647,478    975,727 
If converted shares   19,698,961     
Dilutive weighted average Common Stock outstanding   136,346,439    975,727 
Diluted net income per Common Stock  $0.05   $(0.52)
SCHEDULE OF DILUTIVE INSTRUMENTS

Below is a summary of the potentially dilutive instruments as of March 31, 2026 and 2025:

 

Description  March 31, 2026   March 31, 2025 
Sellers Notes       13,214,028 
Convertible notes - Chardan       1,594,763 
Secured convertible note   14,169,724    11,333,505 
Winston & Strawn agreement       1,034,381 
Tau agreement       888,973 
Debenture   3,555,553     
Unissued Stock Based compensation shares   1,973,684     
Promissory note       6,040 
Total Shares issuable under Convertible Note obligations – if converted total dilutive   19,698,961    28,071,690 
           
Public Warrants   10,062,500    10,062,500 
Private Warrants   5,553,125    5,553,125 
2025 Warrants   16,258,332     
Secured convertible note warrants   600,000    600,000 
Total excluded under treasury method – out of the money   32,473,957    16,215,625